Infection Prevention & Control: PPE and Beyond. Stacy Martin, RN, BSN, CIC Manager, Infection Prevention & Control

Similar documents
Infection Prevention Highlights for the Medical Staff. Pamela Rohrbach MSN, RN, CIC Director of Infection Prevention

Safe Patient Care Keeping our Residents Safe Use Standard Precautions for ALL Residents at ALL times

Preventing Multi-Drug Resistant Organism (MDRO) Infections. For National Patient Safety Goal

Imagine. Multi-Drug Resistant Superbugs- What s the Big Deal? A World. Without Antibiotics. Where Simple Infections can be Life Threatening

Multi-Drug Resistant Organisms (MDRO)

Antibiotic Resistance in the Post-Acute and Long-Term Care Settings: Strategies for Stewardship

Infectious Disease in PA/LTC an Update. Karyn P. Leible, MD, CMD, FACP October 2015

Hand washing/hand hygiene reduces the number of microorganisms on the hands and is the most important practice to prevent the spread of infection.

Florida Health Care Association District 2 January 13, 2015 A.C. Burke, MA, CIC

Carbapenemase-Producing Enterobacteriaceae (CPE)

Antibiotic Resistance. Antibiotic Resistance: A Growing Concern. Antibiotic resistance is not new 3/21/2011

APIC CHAPTER PRESENTATION 7/2014

Presented by: Mary McGoldrick, MS, RN, CRNI

Antimicrobial stewardship: Quick, don t just do something! Stand there!

What bugs are keeping YOU up at night?

CONTAGIOUS COMMENTS Department of Epidemiology

TABLE OF CONTENTS. 1. Purpose of the WRHA Infection Prevention and Control Manual 2.1 and approval process

Infection Control of Emerging Diseases

Other Enterobacteriaceae

1/30/ Division of Disease Control and Health Protection. Division of Disease Control and Health Protection

The importance of infection control in the era of multi drug resistance

Multidrug-Resistant Organisms: How Do We Define them? How do We Stop Them?

Testimony of the Natural Resources Defense Council on Senate Bill 785

18/08/2016. Safe Patient Care. Keeping our Residents Safe. Background. Infection Prevention and Control developing over the last 40 years

Multi-drug resistant microorganisms

MICRO-ORGANISMS by COMPANY PROFILE

Taking Action to Prevent and Manage Multidrug-resistant Organisms and C. difficile in the Nursing Home: Part 1 Reviewing the organisms

03/09/2014. Infection Prevention and Control A Foundation Course. Talk outline

North West Neonatal Operational Delivery Network Working together to provide the highest standard of care for babies and families

5/4/2018. Multidrug Resistant Organisms (MDROs) Objectives. Outline. Define a multi-drug resistant organism (MDRO)

Nosocomial Antibiotic Resistant Organisms

Clinic Infectious Disease Control

Infection Control and Standard Precautions

Keeping Antibiotics Working: Nursing Leadership in Action

Rise of Resistance: From MRSA to CRE

Human health impacts of antibiotic use in animal agriculture

11/22/2016. Hospital-acquired Infections Update Disclosures. Outline. No conflicts of interest to disclose. Hot topics:

Geriatric Mental Health Partnership

Version Control Sheet

Your Guide to Managing. Multi Drug-resistant Organisms (MDROs)

GUIDE TO INFECTION CONTROL IN THE HOSPITAL. Antibiotic Resistance

Hand Hygiene and MDRO (Multidrug-resistant Organisms) - Science and Myth PROF MARGARET IP DEPT OF MICROBIOLOGY

Antibiotics in the future tense: The Application of Antibiotic Stewardship in Veterinary Medicine. Mike Apley Kansas State University

Today s Agenda: 9/30/14

Infection Prevention & Control in Ambulatory Surgical Centers. Objectives

28/08/2017. Infection Prevention and Control. Safe Patient Care Bugs and Drugs The ongoing challenge of MDROs and AMR

3/1/2016. Antibiotics --When Less is More. Most Urgent Threats. Serious Threats

Two (II) Upon signature

INCIDENCE OF BACTERIAL COLONISATION IN HOSPITALISED PATIENTS WITH DRUG-RESISTANT TUBERCULOSIS

WHO laboratory-based global survey on multidrug-resistant organisms (MDROs) in health care interim analysis

In-Service Training Program. Managing Drug-Resistant Organisms in Long-Term Care

The Spread of the Superbug

Multi-Drug Resistant Gram Negative Organisms POLICY REVIEW DATE EXTENDED Printed copies must not be considered the definitive version

New Opportunities for Microbiology Labs to Add Value to Antimicrobial Stewardship Programs

Invasive Group A Streptococcus (GAS)

Antimicrobial Stewardship Strategy: Antibiograms

Carbapenemase-Producing Enterobacteriaceae Multi Drug Resistant Organism Management Procedure. (IPC Manual)

Recommendations for Implementation of Antimicrobial Stewardship Restrictive Interventions in Acute Hospitals in Ireland

Antibiotic resistance: how did we get here and what can we do? Peter Lambert LHS

Overview of Infection Control and Prevention

This coloring book from the Texas Department of State Health Services provides education for children related to antibiotic resistance.

Consequences of Antimicrobial Resistant Bacteria. Antimicrobial Resistance. Molecular Genetics of Antimicrobial Resistance. Topics to be Covered

MID 23. Antimicrobial Resistance. Consequences of Antimicrobial Resistant Bacteria. Molecular Genetics of Antimicrobial Resistance

Hand washing, Asepsis, Precautions and Infection Control

Antimicrobial Resistance

Antimicrobial Resistance Acquisition of Foreign DNA

New Drugs for Bad Bugs- Statewide Antibiogram

The Spread of the Superbug

Hospital Acquired Infections in the Era of Antimicrobial Resistance

Hospital ID: 831. Bourguiba Hospital. Tertiary hospital

: "INFECTION CONTROL: WHAT'S COMING IN 2017?" LISA THOMAS RN-BC STATE TRAINING COORDINATOR OFFICE OF LONG TERM CARE

ANTIBIOTIC RESISTANCE. Syed Ziaur Rahman, MD, PhD D/O Pharmacology, JNMC, AMU, Aligarh

Antimicrobial Cycling. Donald E Low University of Toronto

Antimicrobial Stewardship. Where are we now and where do we need to go?

MDRO in LTCF: Forming Networks to Control the Problem

Presenter: Ombeva Malande. Red Cross Children's Hospital Paed ID /University of Cape Town Friday 6 November 2015: Session:- Paediatric ID Update

ANTIBIOTIC RESISTANCE THREATS. in the United States, 2013

TABLE OF CONTENTS Foreword...5 Executive Summary...6 Section 1: The Threat of Antibiotic Resistance...11 Introduction...11 National Summary Data...

running head: SUPERBUGS Humphreys 1

Service Delivery and Safety Department World Health Organization, Headquarters

Prevention, Management, and Reporting of Carbapenem-Resistant Enterobacteriaceae

Summary of the latest data on antibiotic resistance in the European Union

CUMULATIVE ANTIBIOGRAM

MICRONAUT MICRONAUT-S Detection of Resistance Mechanisms. Innovation with Integrity BMD MIC

Other Beta - lactam Antibiotics

Is biocide resistance already a clinical problem?

9/30/2016. Dr. Janell Mayer, Pharm.D., CGP, BCPS Dr. Lindsey Votaw, Pharm.D., CGP, BCPS

Appropriate antimicrobial therapy in HAP: What does this mean?

Nosocomial Infections: What Are the Unmet Needs

WHO s first global report on antibiotic resistance reveals serious, worldwide threat to public health

Why Don t These Drugs Work Anymore? Biosciences in the 21 st Century Dr. Amber Rice October 28, 2013

Reportable Disease Surveillance & Antibiotic Resistant Bacteria

Do Bugs Need Drugs? A community program for wise use of antibiotics

Can you treat mrsa with amoxicillin

Implementing Antibiotic Stewardship in Rural and Critical Access Hospitals

ANTIMICROBIAL RESISTANCE

Antibiotic stewardship in long term care

MDRO s, Stewardship and Beyond. Linda R. Greene RN, MPS, CIC

Does Screening for MRSA Colonization Have A Role In Healthcare-Associated Infection Prevention Programs?

Public Health Response to Emerging Resistance

Transcription:

Infection Prevention & Control: PPE and Beyond Stacy Martin, RN, BSN, CIC Manager, Infection Prevention & Control

Objectives Describe the chain of infection Explain the role of personal protective equipment (PPE)in interruption of transmission of infection List the proper order for donning & doffing PPE Describe issue of emerging antibiotic resistance

Chain of Infection Susceptible Host Pathogen Entry Source Mode

Interrupting Transmission Breaking any link in the chain Examples Eliminate the pathogen Eliminate portal of entry Modify status of susceptible host Interrupt mode of transmission

Eliminate Causative Agent/ Reservoir Types of Pathogens Bacteria Virus Fungi Eliminate the Pathogen or Reservoir Antibiotics/antivirals/antifungals Disinfection of surfaces/equipment

Minimize Portal of Entry Invasive devices Foley Central Lines Vent Maintain skin integrity Incisions Decubitus Skin tears

Susceptible Host Modifiable vs Non-modifiable Age Immune status Comorbidities Vaccinate Discharge!!!

Interrupt Transmission Hand hygiene #1 method to prevent the spread of infection! Monitoring Activities What is ultimate message???

Stop Transmitting Infections!

When asking healthcare workers to wash their hands, perhaps a better message would be to ask them not to transmit disease. This changes the emphasis from a single act of adherence to a concept of behavior change.

Interrupt Transmission, cont Personal Protective Equipment Gowns Gloves Eye shields Masks Universal Precautions vs. Standard Precautions

Universal Precautions Developed by OSHA Treat all blood and certain body fluids as infectious Target HIV, Hepatitis B, Hepatitis C

Standard Precautions Developed by CDC to protect care givers from spread of infectious diseases by all modes Expanded Universal Precautions to include all blood body fluids, secretions, and excretions (except sweat) bloody or not non-intact skin mucous membranes

Transmission Based Precautions Standard Precautions plus Contact Droplet Airborne Choose PPE according to anticipated exposure

PPE Then 14 th Century Plague Doctor Hat Mask (Beak) Glasses/goggles Gown Pointer https://www.cdc.gov/plague/history/index.html

PPE Now

Too Basic?? Consider this. Severe Acute Respiratory Syndrome (SARS)- 2003 Middle East Respiratory Syndrome (MERS)- 2012 Ebola-2013 All implicated improper removal of PPE in transmission of infection to HCW

Characteristics of the SARS outbreak in the greater Toronto Area and Taiwan, March-June 2003 Characteristic GTA, no. (%) Taiwan, no. (%) b Total cases 375 NA Probable 247 (66) 668 Suspected 128 (34) NA Deaths 44 (12) 72 (11) Healthcare related 271 (72) 370 (55) Healthcare workers 164 (44) 120 (18) Patients or visitors 107 (28) 256 (38) Hospitals with hospitalized SARS patients Hospitals with SARS transmission Hospitals that closed wards or an emergency room 23 84 10 (43) 8 (10) 10 (43) NA a SARS, severe acute respiratory syndrome; GTA, greater Toronto area; NA, data not available b Percentage expresses proportion of all probable SARS cases McDonald LC, Simor AE, Su I-J, Malone S, Ofner M, Chen K-T, et al. SARS in healthcare facilities, Toronto and Taiwan. Emerg Infect Dis [serial on the Internet] 2004 May [date cited]. Available from: http://www.cdc.gov/ncidod/eid/vol10no5/03-0791.htm

Esswein, E. J., Kiefer, M., Wallingford, K., Burr, G., Lee, L. J., Wang, J...Su, I. (2004). Environmental and Occupational Health Response to SARS, Taiwan, 2003. Emerging Infectious Diseases, 10(7), 1187-1194. https://dx.doi.org/10.3201/eid1007.030728.

MERS In the US Two unrelated cases Indiana & Florida Both healthcare workers in Saudi Arabia Study in Thailand supported use of PPE to prevent transmission Tested HCW with known exposure (avg 35 min) with PPE All samples negative

EBOLA HCW Guinea 162 (7.9 %) cases were HCW 42.2 times higher than non HCW Guinea: doctors > nurses Sierra Leone nurses > doctors Reference: Ebola Virus Disease in Health Care Workers Guinea, 2014 MMWR October 2, 2015 / 64(38);1083-1087

EBOLA, cont. US Ebola Experience Oct 10, 2014 HCW tested + Ebola after caring for an imported case Oct 15, 2014 2 nd HCW tested + Also cared for index case

Example of Checklist for Donning/Doffing for Ebola

Current Compliance Studies ER study - 1999 Observed 88 videotaped cases Major break (involved in invasive procedure) observed in 33.6% Minor break (adjacent to patient) observed in 55.5% Most common = no eye protection

Current Compliance Studies, cont. 2009 Canadian Study More experienced HCW are more compliant 2013 Canadian PPE Study (Resp Illness) 34% donned all PPE required 54% doffed in correct sequence (MDs worst) 9% did not perform HH 2013 Canadian Mask Study 11% performed 6 necessary steps for correct donning ER nurses least compliant

Current Compliance Studies, cont. 2014 US PPE Study Observed 30 HCW in Contact Isolation remove PPE 17% correct order & correct disposal 53% wore PPE in hall 2015 PPE Training Survey 14% MDs reported no PPE training 18% agreed HH not needed if gloves are used 29% interested in receiving training

Influences on Compliance Organizational culture User input in selection Comfort Time Availability Belief PPE interferes w/ nurse-patient relationship Education When and how

PPE Donning & Doffing Purposeful Careful Slow Gentle

Proper Donning

Proper Doffing

Live Demo Donning Gown Mask Goggle/Face shield Gloves Doffing Gloves Goggles/face shield Gown Mask

The more we look at drug resistance, the more concerned we are. It basically shows us that the end of the road isn't very far away for antibiotics. Tom Frieden, Director, Centers for Disease Control & Prevention https://www.brainyquote.com/quotes/quotes/t/tomfrieden763145.html?src=t_antibiotic

Multi-drug Resistant Organisms (MRDO) Definition: MDROs are defined as microorganisms, predominantly bacteria, that are resistant to one or more classes of antimicrobial agents. Although the names of certain MDROs describe resistance to only one agent (e.g., MRSA, VRE), these pathogens are frequently resistant to most available antimicrobial agents. CDC, Management of Multidrug-Resistant Organisms In Healthcare Settings, 2006

How Antibiotic Resistance Happens 1. Lots of germs. A few are drug resistant. 2. Antibiotics kill bacteria causing the illness, as well as good bacteria protecting the body from infection 3. The drug-resistant bacteria are now allowed to grow and take over. 4. Some bacteria give their drug-resistance to other bacteria, causing more problems. https://www.cdc.gov/drugresistance/threat-report-2013/pdf/ar-threats-2013-508.pdf#page=13

https://www.cdc.gov/drugresistance/threat-report-2013/pdf/ar-threats-2013-508.pdf#page=13

Evolution of Antibiotic Resistance 1940 s Penicillin available for medical use 1967-1 st penicillin resistant strep 1980-3-5% resistant 1998-34% resistant MRSA (Methicillin-resistant Staph Aureus) 1961-MRSA identified in England 1968-MRSA identified in United States (Boston)

Evolution of Antibiotic Resistance, cont VRE (Vancomycin Resistant Enterococci) 1988-1 st report of VRE 20 fold increase from 1989 (0.3%) to 1993 (7.9%) Bacteremia associated with high mortality

Evolution of Antibiotic Resistance, cont ESBL s 1980s identified enzymes (beta-lactamase) produced by Klebsiella & E coli that destroyed the extended spectrum cephalosporins Enzymes do not affect carbapenems Many are also genetically resistant to multiple antibiotics Difficult to detect in lab Resistance is encoded by genes located on plasmids, resulting in easy transfer to other species

Evolution of Antibiotic Resistance, cont Most ESBL s still susceptible to : Cefoxitin Cefotetan Meropenem Imipenem Carbapenems are treatment of choice

Evolution of Antibiotic Resistance, cont Now there are carbapenem resistant organisms; commonly called KPC or CRE Typically in the Enterobacteriaceae family Klebsiella species E. coli Proteus mirabilis Enterobacter cloacae Several mechanisms to cause resistance Produce enzyme (carbepenemase) causes resistance to carbapenems (KPC) Carbapenemase production not confined to one bacteria indicating that there is plasmid transfer capability

Colistin Resistance Discovered Colistin is one of the last efficacious antibiotics for the treatment of highly resistant bacteria.... The gene is transferrable to other bacteria, which could worsen the current global crisis of antimicrobial resistance. An urgent public health response is underway to contain and prevent potential spread of mcr-1. May 26, 2016

Impact on Oncology Patient High mortality up to 50% if bacteremic Increase C.diff infections HAI cycle LOS - Risk of Infection - Need for abx Delay treatment Increased cost/los Impact on prophylaxis/treatment options

Combating Resistance CDC Four Core Actions Prevent infections- prevents spread of resistance Track/Collect Information-rapid detection Improve antibiotic use/stewardship Develop drugs and diagnostic tests https://www.cdc.gov/drugresistance/index.html

Combating Resistance, cont Personal Contributions Prevent spread of infections/resistance Learn proper techniques Perform hand hygiene Use PPE properly all of the time Improve antibiotic use Review drug bug results in your pts Don t insist on abx when sick Complete abx prescription as indicated Educate your patients and your families

I Spy! Demo of Incorrect PPE Donning Doffing Special thanks to our model!!

Final Thought Some experts say we are moving back to the pre-antibiotic era. No. This will be a post-antibiotic era. In terms of new replacement antibiotics, the pipeline is virtually dry. A postantibiotic era means, in effect, an end to modern medicine as we know it. Things as common as strep throat or a child's scratched knee could once again kill. Margaret Chan, Director General, World Health Organization https://www.brainyquote.com/quotes/quotes/m/margaretch516579.html?src=t_antibiotics